Melanoma EA6192
Study #EA6192A Phase II Study of Biomarker Driven Early Discontinuation of anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)
Back To Clinical Trials NCI Database EntryA Phase II Study of Biomarker Driven Early Discontinuation of anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)
Back To Clinical Trials NCI Database Entry